MACROGENICS, INC. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
MACROGENICS, INC. (MGNX) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 100.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2026-03-09
- MACROGENICS, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2025 was 100.00%, a 0.00% change from fiscal 2024.
- MACROGENICS, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2024 was 100.00%, a 0.00% change from fiscal 2023.
- MACROGENICS, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2023 was 100.00%, a 0.00% change from fiscal 2022.
- MACROGENICS, INC. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2022 was 100.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 0 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 1 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|---|---|---|
| 2025-12-31 | 100.00% 10-K · filed 2026-03-09 | |||
| 2024-12-31 | 100.00% 10-K · filed 2025-03-20 | |||
| 2023-12-31 | 100.00% 10-K · filed 2024-03-07 | |||
| 2022-12-31 | 100.00% 10-K · filed 2023-03-15 | |||
| 2021-12-31 | 100.00% 10-K · filed 2022-02-24 | |||
| 2014-12-31 | 100.00% 10-K · filed 2021-02-25 | |||
| 2013-12-31 | 100.00% 10-K · filed 2020-02-25 | |||
| 2012-12-31 | 100.00% 10-K · filed 2019-02-26 | |||
| 2002-09-30 | 100.00% 10-Q · filed 2013-11-12 | |||
| 2002-09-25 | 100.00% 10-K · filed 2014-03-20 | 100.00% 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |